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Objectives: Vascular interventional procedures often
lead to endothelial denudation exposing vascular smooth
muscle cells (SMCs) to fluid shear stress (FSS) exerted by
the flowing blood. Intimal hyperplasia has been previously
found to be influenced by Endothelin-1 (Et-1) through its
receptors A and B (Et (A)/Et (B)). This study aimed to
investigate the regulation of Et-1 and Et (A)/Et (B) by FSS
in SMCs.
Methods: Rat aortic SMCs were exposed to FSS (14
dynes/cm2, 24 h) and endothelin-associated gene expression
studied using microarrays. Cells were also were subjected to
low shear (5 dynes/cm2) or high shear (14 dynes/cm2) and
the expression of Et-1 and its receptors studiedwithRT-PCR.
Following balloon injury to the rat carotid artery, RNA was
isolated at 0-20 h after injury and expression of endothelin-
associated genes studied with microarray technology. 10 days
after injury, carotid arteries were studied by immunohisto-
chemistry (IHC) using an Et (B) receptor antibody.
Results: Array analysis showed a decrease of Et-1
mRNA with a signal log ratio (SLR) of5 (p 0.0025) in
FSS exposed SMCs in vitro. RT-PCR revealed an mRNA
quantity of 29.9% (p  0.001) and 13.3% (p  0.001) for
the low and high FSS group, respectively. Et (B) receptor
mRNA was upregulated by FSS in SMCs (SLR 4.4, p 
0.025). RT-PCR showed a consistent upregulation (p 
0.001) in the low- and high FSS groups, but no significant
dose-response effect (945.9% and 733.4% for the low- and
high FSS groups vs control, respectively). Et (A) receptor
expression was increased in the low FSS group (381.7%,
p  0.001) compared to control, but no increase was seen
in the high FSS group. Following rat carotid injury, Et (B)
receptor mRNA was upregulated at 5, 10 and 20 h by
388.3%, 495.4% and 141.9%, respectively (p 0.05). IHC
showed a prominent Et (B) receptor expression in adlumi-
nal SMCs exposed to FSS.
Conclusions: This data suggests that Et-1 and its
receptors are regulated by FSS in SMCs. Further studies of
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Objectives: Edaravone (Radicut®, Mitsubishi Tanabe
Pharma Co., JAPAN), the first free-radical scavenger is
presently used for acute cerebral infarction patients. We
aimed to evaluate whether edaravone suppresses reperfu-
sion injury focusing onmitochondrial activity and glycogen
storage in the lower extremity muscles.
Methods: Male Lewis rats (508 35 gm) were admin-
istrated a preoperative intraperitoneal injection of edara-
vone (3.0 mg/kg, edaravone group, n  8) or the same
dose of saline (control group, n  8). Both common
femoral arteries were clamped for 5 hours, and then
declamped. The muscles of the bilateral lower extremities
were harvested after more 5 hours from the start of reper-
fusion. They were stained with cytochrome-c oxidant as
mitochondrial activity, and Periodic Acid Schiff (PAS) as
glycogen storage. The percentages of cytochrome-c
oxidant area and PAS area were measured and compared.
Results: The mean percentage of cytochrome-c oxi-
dant area in the edaravone group was significantly higher
than that in controls (13.3  1.2 % vs 0.8  0.1%, p 
0.01). Themean percentage of PAS area in the edaravone
group was also significantly higher than that in controls
(51.7  6.8 % vs 7.3  2.1%, p  0.001, Fig. attached).
Conclusions: Our results suggested that edaravone
might suppress reperfusion injury after leg ischemia by
keeping a high level of mitochondrial activity, resulted in
also a high level of glycogen storage in muscles.
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